Influence of TAAR6 polymorphisms on response to aripiprazole

[1]  A. Serretti,et al.  Immediate versus gradual suspension of previous treatments during switch to aripiprazole: Results of a randomized, open label study , 2009, European Neuropsychopharmacology.

[2]  A. Serretti,et al.  TAAR6 variation effect on clinic presentation and outcome in a sample of schizophrenic in-patients: An open label study , 2008, European Psychiatry.

[3]  C. Swanson,et al.  The Trace Amine 1 receptor knockout mouse: an animal model with relevance to schizophrenia , 2007, Genes, brain, and behavior.

[4]  Patrick F. Sullivan,et al.  Spurious Genetic Associations , 2007, Biological Psychiatry.

[5]  Vladimir I. Vladimirov,et al.  A region of 35 kb containing the trace amine associate receptor 6 (TAAR6) gene is associated with schizophrenia in the Irish study of high-density schizophrenia families , 2007, Molecular Psychiatry.

[6]  T. Hicks,et al.  The mysterious trace amines: Protean neuromodulators of synaptic transmission in mammalian brain , 2006, Progress in Neurobiology.

[7]  D. Lancet,et al.  The trace amine receptor 4 gene is not associated with schizophrenia in a sample linked to chromosome 6q23 , 2006, Molecular Psychiatry.

[8]  M. Ikeda,et al.  No association of haplotype-tagging SNPs in TRAR4 with schizophrenia in Japanese patients , 2005, Schizophrenia Research.

[9]  M. Hoener,et al.  A renaissance in trace amines inspired by a novel GPCR family. , 2005, Trends in pharmacological sciences.

[10]  S. Cichon,et al.  A family-based and case–control association study of trace amine receptor genes on chromosome 6q23 in bipolar affective disorder , 2005, Molecular Psychiatry.

[11]  Martin Ebeling,et al.  Trace amine-associated receptors form structurally and functionally distinct subfamilies of novel G protein-coupled receptors. , 2005, Genomics.

[12]  M. Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[13]  Pablo V Gejman,et al.  Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. , 2004, American journal of human genetics.

[14]  Abraham Weizman,et al.  COMT: A common susceptibility gene in bipolar disorder and schizophrenia , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[15]  M. Laruelle,et al.  Glutamate, Dopamine, and Schizophrenia , 2003 .

[16]  Ricardo Segurado,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part I: Methods and power analysis. , 2003, American journal of human genetics.

[17]  Leena Peltonen,et al.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. , 2003, American journal of human genetics.

[18]  D. Grandy,et al.  Amphetamine, 3,4-methylenedioxymethamphetamine, lysergic acid diethylamide, and metabolites of the catecholamine neurotransmitters are agonists of a rat trace amine receptor. , 2001, Molecular pharmacology.

[19]  Beth Borowsky,et al.  Trace amines: Identification of a family of mammalian G protein-coupled receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Shaw,et al.  A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees. , 2001, American journal of human genetics.

[21]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Hornik,et al.  Genome Scan for Susceptibility Loci for Schizophrenia , 2000, Neuropsychobiology.

[23]  P. Holmans,et al.  Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. , 2000, American journal of human genetics.

[24]  R. Murray,et al.  Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11 , 2000, Molecular Psychiatry.

[25]  N. Andreasen,et al.  Follow-up study on a susceptibility locus for schizophrenia on chromosome 6q. , 1999, American journal of medical genetics.

[26]  T. Matise,et al.  NIMH Genetics Initiative Millenium Schizophrenia Consortium: linkage analysis of African-American pedigrees. , 1998, American journal of medical genetics.

[27]  E. Gershon,et al.  Suggestive evidence for a schizophrenia susceptibility locus on chromosome 6q and a confirmation in an independent series of pedigrees. , 1997, Genomics.

[28]  D. F. Roberts,et al.  The History and Geography of Human Genes , 1996 .

[29]  Bruce A. Davis,et al.  The trace amines and their acidic metabolites in depression — an overview , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[30]  N. Andreasen.  The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical Foundations , 1989, British Journal of Psychiatry.

[31]  T. Barnes.  A Rating Scale for Drug-Induced Akathisia , 1989, British Journal of Psychiatry.

[32]  S. Potkin,et al.  Phenylethylamine in paranoid chronic schizophrenia. , 1979, Science.

[33]  A. Coppen,et al.  Decreased cerebrospinal fluid concentration of free phenylacetic acid in depressive illness. , 1979, Clinica chimica acta; international journal of clinical chemistry.

[34]  A. Flemenbaum,et al.  Inter- and Intra-Rater Reliability of the Brief Psychiatric Rating Scale , 1973, Psychological reports.

[35]  G. Simpson,et al.  A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTS , 1970, Acta psychiatrica Scandinavica. Supplementum.

[36]  W. Marks.  Deep Brain Stimulation Management: Abnormal Involuntary Movement Scale , 2010 .

[37]  B. Lerer,et al.  Association of the trace amine associated receptor 6 (TAAR6) gene with schizophrenia and bipolar disorder in a Korean case control sample. , 2008, Journal of psychiatric research.

[38]  D. Presti,et al.  Endogenous psychoactive tryptamines reconsidered: an anxiolytic role for dimethyltryptamine. , 2005, Medical hypotheses.

[39]  B. Kerem,et al.  Genome scan of Arab Israeli families maps a schizophrenia susceptibility gene to chromosome 6q23 and supports a locus at chromosome 10q24 , 2003, Molecular Psychiatry.

[40]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[41]  T. Hergueta,et al.  The mini international neuropsychiatric interview , 1998, European Psychiatry.